Accumulation of Arsenic Speciation and In Vivo Toxicity Following Oral Administration of a Chinese Patent Medicine Xiao-Er-Zhi-Bao-Wan in Rats

• Главные авторы: Jiaoyang Luo (Автор), Xu Han (Автор), Xiaowen Dou (Автор), Lei Zhang (Автор), Shihai Yang (Автор), Meihua Yang (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2017-07-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Realgar-containing traditional Chinese medicines such as Xiao-Er-Zhi-Bao-Wan (XEZBW), have been widely used for thousands of years. However, events associated with arsenic-induced ailments have increasingly become a public concern. To address the toxicity of XEZBW, we studied the histopathology and...